Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Vandenberg

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cell Death & Disease|January 15, 2016
FoxO3 suppresses Myc-driven lymphomagenesisC J Vandenberg, N Motoyama, S Cory
Journal of Molecular Evolution|June 18, 1998
Variable substitution rates of the 18 domain sequences in Artemia hemoglobinC M Matthews, C J Vandenberg, C N Trotman
Oncogene|December 8, 2015
Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53L J Valente, S Grabow, C J Vandenberg, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1980
Orthophosphate treatment in calcium urolithiasisL H Smith, P G Werness, C J VanDenBerg, et al.
Cell Death and Differentiation|January 28, 2014
Loss of Bak enhances lymphocytosis but does not ameliorate thrombocytopaenia in BCL-2 transgenic miceC J Vandenberg, E C Josefsson, K J Campbell, et al.
Cell Death & Disease|April 17, 2015
BCL-2 is dispensable for thrombopoiesis and platelet survivalM A Debrincat, I Pleines, M Lebois, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cell Death & Disease|January 15, 2016
FoxO3 suppresses Myc-driven lymphomagenesisC J Vandenberg, N Motoyama, S Cory
Journal of Molecular Evolution|June 18, 1998
Variable substitution rates of the 18 domain sequences in Artemia hemoglobinC M Matthews, C J Vandenberg, C N Trotman
Oncogene|December 8, 2015
Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53L J Valente, S Grabow, C J Vandenberg, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1980
Orthophosphate treatment in calcium urolithiasisL H Smith, P G Werness, C J VanDenBerg, et al.
Cell Death and Differentiation|January 28, 2014
Loss of Bak enhances lymphocytosis but does not ameliorate thrombocytopaenia in BCL-2 transgenic miceC J Vandenberg, E C Josefsson, K J Campbell, et al.
Cell Death & Disease|April 17, 2015
BCL-2 is dispensable for thrombopoiesis and platelet survivalM A Debrincat, I Pleines, M Lebois, et al.
Pageof 1